Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9

Journal of Clinical Oncology

Volumn 14, Issue 12, 1996, Pages 3133-3140

  Zeng, Z S ^a   Huang, Y ^a   Cohen, A M ^a   Guillem, J G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; RNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0009708546     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.12.3133     Document Type: Article

References (46)

1. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327-336, 1991
2. Matrisian LM: The matrix-degrading metalloproteinases. Bioessays 14:455-463, 1992
3. Gottesman MM: Introduction: Do proteases play a role in cancer? Semin Cancer Biol 1:97-98, 1990
4. Jessup JM: Cathepsin B and other proteases in human colorectal carcinoma. Am J Pathol 145:253-262, 1994
5. Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65, 1994
6. Will H, Hinzmann B: cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231:602-608, 1995
7. Takino T, Sato H, Shinagawa A, et al: Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 270:23013-23020, 1995
8. Puente XS, Pendas AM, Llano E, et al: Molecular cloning of a novel memebrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56:944-949, 1996
9. Noel A, Santavicca M, Stoll I, et al: Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities. J Biol Chem 270:22866-22872, 1995
10. Woessner JF Jr: The family of matrix metalloproteinases. Ann NY Acad Sci 732:11-21, 1994
11. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735, 1995
12. Forster SJ, Talbot IC, Claytin DG, et al: Tumor basement membrane laminin in adenocarcinoma of the rectum: An immunohistochemical study of biologic and clinical significance. Int J Cancer 37:813-817, 1986
13. Bernhard EJ, Gruber SB, Muschel RJ: Direct evidence linking expression of matrix metalloproteinase 9 (92 kDa genatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 91:4293-4297, 1994
14. Pyke C, Ralkiaer E, Tryggvason K, et al: Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142:359-365, 1993
15. Emmert-Buck MR, Roth MJ, Zhuang Z, et al: Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 145:1285-1290, 1994
16. Zeng ZS, Guillem JG: Distict pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 72:575-582, 1995
17. Davies B, Miles DW, Happerfield LC, et al: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67:1126-1131, 1993
18. Davies B, Waxman J, Wasan H, et al: Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53:5365-5369, 1993
19. Hamdy FC, Fadlon D, Cottam D, et al: Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 69:177-182, 1994
20. Brown PD, Bloxidge RE, Stuart NSA, et al: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non - small-cell lung carcinoma. J Natl Cancer Inst 85:574-578, 1993
21. Pyke C, Ralfkiaer E, Huhtala P, et al: Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 52:1336-1341, 1992
22. Rao JS, Steck PA, Mohanam S, et al: Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 53:2208-2211, 1993
23. Nakajima M, Morikawa K, Fabra A, et al: Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82:1890-1898, 1990
24. Ogata Y, Ookita A, Kakegawa T: Significance of MMP-9 and TIMP-1 production during liver metastases in colorectal cancer. Nippon Rinsho 53:1811-1815, 1995
25. Zucker S, Lysik RM, Zarrabi MH, et al: M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 53:140-146, 1993
26. Zeng ZS, Hsu S, Zhang ZF, et al: High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer 70:1025-1030, 1994
27. Miller R, Siegmund D: Maximally selected chi square statistics. Biometrics 38:101 1-1016, 1982
28. UICC:TNM Atlas Illustrated Guide to the TNM/pTNM Classification of Malignant Tumor. Berlin, Germany, Springer-Verlag, 1992
29. Campo E, Munoz J, Miquel R, et al: Cathepsin B expression in colorectal carcinoma correlates with tumor progression and shortened patient survival. Am J Pathol 145:301-309, 1994
30. Ballin M, Gomez DE, Sinha CC, et al: Ras oncogene mediated induction of a 92 kDa metalloproteinase; Strong correlation with the malignant phenotype. Biochem Biophys Res Commun 154:832-838, 1988
31. Moll UM, Youngleib GL, Rosinski KB, et al: Tumor pro- moter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT 1080 tumor cells. Cancer Res 50:6162-6170, 1990
32. Turpeenniemi-Hujanen T, Thorgeirssion UP, Hart IR, et al: Expression of collagenese IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastastic potential. J Natl Cancer Inst 75:99-103, 1985
33. Yamagata S, Ito Y, Tanaka R, et al: Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. Biochem Biophys Res Commun 151:158-162, 1988
34. Havenith MG, Arends JW, Simon R, et al: Type IV collagen immunoreactivity in colorectal cancer: Prognostic value of basement membrane deposition. Cancer 62:2207-2211, 1988
35. Offerhaus GJ, Giardiello FM, Bruijn JA, et al: The value of immunohistochemistry for collagen IV expression in colorectal cancinomas. Cancer 67:99-105, 1991
36. Tandon AK, Clark GM, Chamness GC, et al: Cathepsin D and prognosis in breast cancer. N Engl J Med 322:297-302, 1990
37. Thorpe SM, Rochefort H, Garcia M, et al: Association between high concentration of Mr 52,000 cathepsin D and poor prognosis in primary breast cancer. Cancer Res 49:6008-6014, 1989
38. Spyratos F, Brouillet J-P, Defrenne A, et al: Cathepsin D: An independent prognostic factor for metastases of breast cancer. Lancet 2:1115-1118, 1989
39. Joensuu H, Toikkanen S, Isola J: Stromal cell cathepsin D expression and long-term survival in breast cancer. Br J Cancer 71:155-159, 1995
40. Hsu DW, Efird JT, Hedley-Whyte ET: Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol 147:114-123, 1995
41. Mulcahy HE, Duffy MJ, Gibbons D, et al: Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet 344:583-584, 1994
42. Levy AT, Cioce V, Sobel ME, et al: Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 51:439-444, 1991
43. Yoshimoto M, Itoh F, Yamamoto H, et al: Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers. Int J Cancer 54:614-618, 1993
44. Newell KJ, Witty JP, Rodgers WH, et al: Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 10:199-206, 1994
45. Wang X, Fu X, Brown PD, et al: Matrix metalloproteinases inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54:4726-4728, 1994
46. Anderson IC, Shipp MA, Docherty AJP, et al: Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res 56:715-718, 1996